Paper19969552
Novel angiogenesis inhibitory activity in cinnamon extract blocks VEGFR2 kinase and downstream signaling.
Lu J and 5 others. Carcinogenesis, 2010. Cited by 98 papers, by iCite.
Cite this record
ConductScience Library. Novel angiogenesis inhibitory activity in cinnamon extract blocks VEGFR2 kinase and downstream signaling. Papers, record 19969552. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19969552
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Novel angiogenesis inhibitory activity in cinnamon extract blocks VEGFR2 kinase and downstream signaling.
- PubMed
Topics32
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Angiogenesis Inhibitors | Major topic |
| Cinnamomum zeylanicum | Major topic |
| Endothelial Cells | Major topic |
| Plant Extracts | Major topic |
| Vascular Endothelial Growth Factor Receptor-2 | Major topic |
| Animals | |
| Aorta, Thoracic | |
| Biflavonoids | |
| Breast Neoplasms | |
| Catechin | |
| Cattle | |
| Cell Division | |
| Cell Line, Tumor | |
| Cell Movement | |
| Cells, Cultured | |
| Chick Embryo | |
| Collagen | |
| Drug Combinations | |
| Female | |
| Humans | |
| Laminin | |
| Male | |
| Mice | |
| Mice, SCID | |
| Morphogenesis | |
| Neovascularization, Physiologic | |
| Phosphorylation | |
| Proanthocyanidins | |
| Protein Processing, Post-Translational | |
| Proteoglycans | |
| Signal Transduction | |
| Xenograft Model Antitumor Assays |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA033572 | NCI NIH HHS | United States | P30CA033572 | PubMed and NIH | NIH RePORTER |
| R01 CA115674 | NCI NIH HHS | United States | R01CA115674 | PubMed and NIH | NIH RePORTER |
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17316549 | Cinnamon extract and polyphenols affect the expression of tristetraprolin, insulin receptor, and glucose transporter 4 in mouse 3T3-L1 adipocytes. | Arch Biochem Biophys | 2007 | https://conductscience.org/library/papers/17316549 | PubMed |
| 2 | 17519900 | Mechanisms of adverse effects of anti-VEGF therapy for cancer. | Br J Cancer | 2007 | https://conductscience.org/library/papers/17519900 | PubMed |
| 3 | 12824281 | VEGF differentially activates STAT3 in microvascular endothelial cells. | FASEB J | 2003 | https://conductscience.org/library/papers/12824281 | PubMed |
| 4 | 16253769 | Water-soluble polymeric polyphenols from cinnamon inhibit proliferation and alter cell cycle distribution patterns of hematologic tumor cell lines. | Cancer Lett | 2005 | https://conductscience.org/library/papers/16253769 | PubMed |
| 5 | 12360282 | VEGF and the quest for tumour angiogenesis factors. | Nat Rev Cancer | 2002 | https://conductscience.org/library/papers/12360282 | PubMed |
| 6 | 2178651 | Diet and cancer. A review. | Acta Oncol | 1990 | https://conductscience.org/library/papers/2178651 | PubMed |
| 7 | 17671111 | Molecular pathways for cancer angioprevention. | Clin Cancer Res | 2007 | https://conductscience.org/library/papers/17671111 | PubMed |
| 8 | 17919802 | Tumor angiogenesis--a potential target in cancer chemoprevention. | Food Chem Toxicol | 2008 | https://conductscience.org/library/papers/17919802 | PubMed |
| 9 | 14709014 | Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity. | J Agric Food Chem | 2004 | https://conductscience.org/library/papers/14709014 | PubMed |
| 10 | 19203831 | Cinnamon extract suppresses tumor progression by modulating angiogenesis and the effector function of CD8+ T cells. | Cancer Lett | 2009 | https://conductscience.org/library/papers/19203831 | PubMed |
| 11 | 16777990 | Black raspberries inhibit N-nitrosomethylbenzylamine (NMBA)-induced angiogenesis in rat esophagus parallel to the suppression of COX-2 and iNOS. | Carcinogenesis | 2006 | https://conductscience.org/library/papers/16777990 | PubMed |
| 12 | 3768832 | International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. | Cancer | 1986 | https://conductscience.org/library/papers/3768832 | PubMed |
| 13 | 17408833 | A comparison of chemical, antioxidant and antimicrobial studies of cinnamon leaf and bark volatile oils, oleoresins and their constituents. | Food Chem Toxicol | 2007 | https://conductscience.org/library/papers/17408833 | PubMed |
| 14 | 16633338 | VEGF receptor signalling - in control of vascular function. | Nat Rev Mol Cell Biol | 2006 | https://conductscience.org/library/papers/16633338 | PubMed |
| 15 | 17389758 | Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice. | Cancer Res | 2007 | https://conductscience.org/library/papers/17389758 | PubMed |
| 16 | 11481234 | Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. | FASEB J | 2001 | https://conductscience.org/library/papers/11481234 | PubMed |
| 17 | 4418408 | Overcoming problems of phenolics and quinones in the isolation of plant enzymes and organelles. | Methods Enzymol | 1974 | https://conductscience.org/library/papers/4418408 | PubMed |
| 18 | 19433898 | Cinnamon extract inhibits tau aggregation associated with Alzheimer's disease in vitro. | J Alzheimers Dis | 2009 | https://conductscience.org/library/papers/19433898 | PubMed |
| 19 | 8756718 | Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. | Cell | 1996 | https://conductscience.org/library/papers/8756718 | PubMed |
| 20 | 2156081 | Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. | J Natl Cancer Inst | 1990 | https://conductscience.org/library/papers/2156081 | PubMed |
Cited by59
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 98 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42074243 | Flavonoids as Inhibitors of VEGFR2 Signaling: Structural Insights for the Development of Safer Anti-Angiogenic Therapies. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42074243 | PubMed |
| 41140222 | Therapeutic and Pharmacological Flexibility of Cinnamoyl Compounds: Targeting Multiple Signaling Pathways. | Mini Rev Med Chem | 2026 | https://conductscience.org/library/papers/41140222 | PubMed |
| 38903995 | Advances in pharmacological effects and mechanism of action of cinnamaldehyde. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38903995 | PubMed |
| 38543147 | Natural Compounds and Breast Cancer: Chemo-Preventive and Therapeutic Capabilities of Chlorogenic Acid and Cinnamaldehyde. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/38543147 | PubMed |
| 37655003 | Hepatic regenerative response to long-term consumption of cinnamon-rich diet in aged rats. | Avicenna J Phytomed | 2023 | https://conductscience.org/library/papers/37655003 | PubMed |
| 37215636 | Aqueous Extract of Cinnamon (Cinnamomum spp.): Role in Cancer and Inflammation. | Evid Based Complement Alternat Med | 2023 | https://conductscience.org/library/papers/37215636 | PubMed |
| 36500445 | Tackling the Future Pandemics: Broad-Spectrum Antiviral Agents (BSAAs) Based on A-Type Proanthocyanidins. | Molecules | 2022 | https://conductscience.org/library/papers/36500445 | PubMed |
| 35847334 | Tannic Acid Exhibits Antiangiogenesis Activity in Nonsmall-Cell Lung Cancer Cells. | ACS Omega | 2022 | https://conductscience.org/library/papers/35847334 | PubMed |
| 35821255 | Anti-proliferative and immunomodulatory potencies of cinnamon oil on Ehrlich ascites carcinoma bearing mice. | Sci Rep | 2022 | https://conductscience.org/library/papers/35821255 | PubMed |
| 35684073 | Therapeutic Potential of Natural Products in the Treatment of Renal Cell Carcinoma: A Review. | Nutrients | 2022 | https://conductscience.org/library/papers/35684073 | PubMed |
| 35445961 | Cinnamon bark extract suppresses metastatic dissemination of cancer cells through inhibition of glycolytic metabolism. | J Nat Med | 2022 | https://conductscience.org/library/papers/35445961 | PubMed |
| 35326241 | Combinatorial Effects of the Natural Products Arctigenin, Chlorogenic Acid, and Cinnamaldehyde Commit Oxidation Assassination on Breast Cancer Cells. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/35326241 | PubMed |
| 34766144 | Alleviating the toxicity concerns of antibacterial cinnamon-polycaprolactone biomaterials for healthcare-related biomedical applications. | MedComm (2020) | 2021 | https://conductscience.org/library/papers/34766144 | PubMed |
| 33719281 | Cinnamon and Hop Extracts as Potential Immunomodulators for Severe COVID-19 Cases. | Front Plant Sci | 2021 | https://conductscience.org/library/papers/33719281 | PubMed |
| 33536908 | Targets and Mechanism Used by Cinnamaldehyde, the Main Active Ingredient in Cinnamon, in the Treatment of Breast Cancer. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/33536908 | PubMed |
| 32665895 | Medicinal Plants Extracts with Antiangiogenic Activity: Where Is the Link? | Adv Pharm Bull | 2020 | https://conductscience.org/library/papers/32665895 | PubMed |
| 32411477 | Effects of Cinnamon (Cinnamomum cassia) Consumption on Serum Lipid Profiles in Albino Rats. | J Lipids | 2020 | https://conductscience.org/library/papers/32411477 | PubMed |
| 32211322 | Neem Leaf Glycoprotein Restrains VEGF Production by Direct Modulation of HIF1α-Linked Upstream and Downstream Cascades. | Front Oncol | 2020 | https://conductscience.org/library/papers/32211322 | PubMed |
| 32140394 | Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent. | Acta Pharm Sin B | 2020 | https://conductscience.org/library/papers/32140394 | PubMed |
| 32133057 | Protective effects of 2-methoxycinnamaldehyde an active ingredients of Cinnamomum cassia on warm hepatic ischemia reperfusion injury in rat model. | Iran J Basic Med Sci | 2019 | https://conductscience.org/library/papers/32133057 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| KDR | 3791 | PubTator's text mining | https://conductscience.org/library/genes/3791 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19969552
GET https://conductscience.org/api/papers/v1/19969552/references?page=2